Partner

523 West 6th St., Suite 400
Los Angeles, CA 90014

+1213.788.4099

40 & Under List

English


Practice area:

Dispute resolution


Praised as a “creative thinker” with “a deft hand” by a client to Chambers, Christine Woodin focuses her practice on complex commercial litigation and intellectual property. She has worked on important cases in a variety of industries – including defending billion-dollar product lines from patent assertions and other claims, managing global patent licensing disputes, pursuing and defending antitrust claims, and handling breach of contract and other critical commercial disputes for her clients.

Ms. Woodin has experience in all aspects of these cases, including counseling on pre-suit strategy, conducting effective offensive and defensive discovery, deposing witnesses and defending depositions, drafting dispositive and pre-trial motions, preparing for trial, presenting witnesses at trial, and handling appeals.  

During law school, Ms. Woodin was a comment editor for the University of Chicago Legal Forum. At the California Institute of Technology (Caltech), Ms. Woodin carried out research in computational applied mathematics and was a recipient of the Monticello Research Fellowship.

Among her accolades, Ms. Woodin was recently named among The Recorder’s “Women Leaders in Tech Law: Litigation,” the Daily Journal’s “Top Intellectual Property Lawyers,” the Los Angeles Times’ “Legal Visionaries,” and the Los Angeles Business Journal’s “Women of Influence: Attorneys.”

  • Obtained a favorable settlement exceeding $300 million in value for Match Group against Google over its illegal monopolization and other anticompetitive behavior in the distribution of mobile apps and processing of in-app purchases. The settlement was recognized with a U.S. Impact Case Award by Benchmark Litigation.

  • Representing AbbVie, a defendant in the Allergan Textured Breast Implant Litigation. This multibillion-dollar litigation involves approximately 1,700 individual lawsuits and over 5,000 total claimants pending in four venues, including multidistrict litigation in the District of New Jersey. The plaintiffs allege AbbVie’s BIOCELL® textured breast implant causes a rare type of cancer and they argue AbbVie is liable under manufacturing defect, failure to warn, and misrepresentation theories.

  • Secured a favorable settlement for Amazon.com in a patent infringement lawsuit in the Eastern District of Texas alleging over a billion in damages for use of Amazon Robotics’ technology in Amazon’s fulfillment centers.

  • Representing Samsung Bioepis against a breach of contract lawsuit brought by Johnson & Johnson and Janssen Biotech concerning Samsung’s manufacture of the biosimilar ustekinumab-ttwe.  

  • Represented Ericsson in a worldwide dispute against Apple over fair, reasonable, and non-discriminatory (FRAND) terms for a cross-license to the parties’ cellular standard-essential patents. After four days of trial in the Eastern District of Texas, the parties announced a global settlement.

  • Arbitration
  • Class action
  • Commercial
  • Commercial and transactions
  • Commercial disputes
  • Competition/antitrust
  • Dispute resolution
  • Intellectual property
  • Plaintiff
  • Product liability and recall

  • Consumer goods and services
  • Energy
  • Government and public policy
  • Healthcare
  • Natural resources
  • Pharmaceutical and life sciences
  • Technology and telecommunications

  • J.D. (with honors) - University of Chicago Law School - 2013
  • B.S., Applied & Computational Mathematics - California Institute of Technology - 2010

  • Ninth Circuit Lawyer Representatives
  • Los Angeles Advisory Board, BEAM

  • California - 2013
  • Texas - 2016